Ceragenix Pharmaceuticals - Research on Use of Ceragenins(TM) as Potential Therapy for Behcet's
Research on Use of Ceragenins(TM) as Potential Therapy for Behcet's
Genetic Engineering News - Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on infectious disease and dermatology, today announced that research by Dr. Emiko Isogai of the University of Hokkaido's School of Dentistry describing in vitro efficacy of a
Ceragenix conducting clinical study of eczema treatment
San Francisco Business Journal - Ceragenix Pharmaceuticals Inc. said Monday it's begun enrolling patients in a pediatric clinical study to assess the effectiveness of its cream to treat eczema. The Denver company (OTCBB: CGXP) expects to report results of the clinical trial in the
Research on Use of Ceragenins(TM) As Potential Therapy for Cystic
dBusinessNews.com - DENVER -- Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC) Ceragenix Pharmaceuticals, Inc. a biopharmaceutical company focused on infectious disease and dermatology, today announced that the American Society of Microbiology
Chemical to block HIV infection identified
Onlypunjab.com - The chemical was developed by scientists at Brigham Young University, Utah, and is licensed to a company called Ceragenix Pharmaceuticals. Brigham Young University and Vanderbilt have jointly filed a patent on the compounds, the report said. US
Colorado business, 7/27
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical